US FDA met with a group concerned about seafood consumption advice for pregnant and nursing women; could it satisfy Sen. Murkowski and avoid a hold on Scott Gottlieb's nomination?
Scott Gottlieb's predecessor in the US FDA Commissioner's office already may have set the wheels in motion to deal with a fishy issue that could hold up his confirmation.
Acting Commissioner Stephen Ostroff, who had been deputy commissioner for foods and veterinary medicine before taking over agency operations at...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
